Optimizing Early Sequencing And Treatment In Mm | Latest News RSS feed

Optimizing Early Sequencing And Treatment In Mm - Latest News

Cellectar’s CLR 131 Receives FDA Rare Pediatric Disease Designation for the Treatment of Ewing’s Sarcoma

Aug. 13, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences (Nasdaq: CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatmen... read more

Leadiant Biosciences to Collaborate with National Institutes of Health on Therapy in Late-Stage Development for GNE Myopathy

ManNAc has been evaluated in two early phase NIH trials in individuals with GNE myopathy ... dependence on a caregiver. DNA sequencing for mutations in the GNE gene confirms the diagnosis of GNE myopa... read more

The Nastiest Feud in Science

But Vincent Courtillot, an early proponent of Deccan volcanism who has closely followed Keller’s work, thinks that prejudice has tainted other scientists’ treatment of her ... in the world support the ... read more

Looking for another news?

Obese Breast Cancer Patients and Survivors: Management Considerations

Women with early-stage breast cancer who are overweight or obese at diagnosis and/or gain weight after diagnosis may have a higher risk of recurrence compared with women of normal weight. Obesity may ... read more


Why hospitals will soon sequence the genes of every single patient

After studying cases and training for years in medical school, doctors are able to identify patterns in a patient’s test results, compare them to that of a healthy individual and come up with a diagno... read more

NanoString Expands Centers of Excellence Program and Initiates Early Access Launch for Digital Spatial Profiling

The company also announced the Early Access ... next-generation sequencing as the read-out platform for DSP. The Broad Institute will use DSP to characterize rare cell populations in tissue to better ... read more

Absent tumor-suppressors allow melanoma to thwart immunotherapy

Whole exome sequencing of ... Longitudinal Learning and Optimization (APOLLO) platform of the Moon Shots Program, co-led by Futreal that systematically gathers samples and data to understand tumor res... read more

Paediatric Antiretroviral Drug Optimization (PADO) Meeting 3

As of 2015, only 6% of children who were on treatment received a second-line ART regimen. This number is expected to increase over the coming years, underscoring the importance of strategic sequencing ... read more

The genomics intelligence revolution

We’ve been using WGS to personalize medicine since 2010, when WGS was first used to inform the treatment of a patient ... We are at the leading edge of an intelligence revolution, powered by sequencin... read more

GenSight Biologics receives Orphan Drug Designation and Advanced Therapy Medicinal Product classification in Europe for GS030 in Retinitis Pigmentosa

“We are very excited that GS030 has received both Orphan Drug Designation and Advanced Therapy Medicinal Product classification in ... treatment for retinitis pigmentosa patients, and the potential of ... read more

The dog as a cancer model

With the recent release of the canine genome sequence, the dog is now also amenable ... and as means to optimize the development of anticancer agents currently in early human trials. Second, data gene... read more

FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us